secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0000950170-25-083088
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology stockholders elect three Class I directors, ratify EY as auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Arthur Kuan, James J. Mulé, Leonard Post elected as Class I directors to serve until 2028 annual meeting.
- Ratification of Ernst & Young as independent auditor for fiscal year ending Dec 31, 2025 was approved with 69.7M votes for, 7K against.
- Broker non-votes of 8.45M shares on director elections; no broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000095017025083088/0000950170-25-083088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000095017025083088/ck0001991792-20250605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer